RS
EDIT icon

R Squared’s Editas Medicine EDIT Stock Holding History

R Squared’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,645
Closed -$31.2K – 573
2026
Q1 		$31.2K Sell
12,645
-1,720
-12% -$3.64K 0.02% 443
2025
Q4 		$29.4K Sell
14,365
-6,260
-30% -$18.1K 0.01% 482
2025
Q3 		$71.6K Hold
20,625
– – 0.03% 461
2025
Q2 		$45.4K Buy
+20,625
New +$33.7K 0.03% 400
2025
Q1 		– Sell
-2,740
Closed -$3.48K – 642
2024
Q4 		$3.48K Buy
+2,740
New +$6.98K ﹤0.01% 1385

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

R Squared's EDIT Position: Q2 2026 in Review

R Squared sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 12,645 shares — an estimated $31.2K sold.

R Squared first reported a position in EDIT in Q4 2024 and held it in 5 quarters. The position peaked at $71.6K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • R Squared reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • R Squared sold 12,645 Editas Medicine shares in Q2 2026, an estimated $31.2K.
  • R Squared first reported a position in Editas Medicine in Q4 2024 and held it in 5 quarters.
  • R Squared's Editas Medicine position peaked at $71.6K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.